476 related articles for article (PubMed ID: 28986598)
1. Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.
Liu H; Anders F; Thanos S; Mann C; Liu A; Grus FH; Pfeiffer N; Prokosch-Willing V
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5129-5141. PubMed ID: 28986598
[TBL] [Abstract][Full Text] [Related]
2. Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.
Vadivel A; Alphonse RS; Ionescu L; Machado DS; O'Reilly M; Eaton F; Haromy A; Michelakis ED; Thébaud B
PLoS One; 2014; 9(3):e90965. PubMed ID: 24603989
[TBL] [Abstract][Full Text] [Related]
3. GYY4137, an Extended-Release Hydrogen Sulfide Donor, Reduces NMDA-Induced Neuronal Injury in the Murine Retina.
Sone K; Mori A; Sakamoto K; Nakahara T
Biol Pharm Bull; 2018; 41(4):657-660. PubMed ID: 29607941
[TBL] [Abstract][Full Text] [Related]
4. Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model.
Huang S; Huang P; Liu X; Lin Z; Wang J; Xu S; Guo L; Leung CK; Zhong Y
Neuroscience; 2017 Jan; 341():27-41. PubMed ID: 27890826
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models.
Wang X; Lin J; Arzeno A; Choi JY; Boccio J; Frieden E; Bhargava A; Maynard G; Tsai JC; Strittmatter SM
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1357-66. PubMed ID: 25655801
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effect of Ginkgo Biloba Extract Against Hypoxic Retinal Ganglion Cell Degeneration
Cho HK; Kim S; Lee EJ; Kee C
J Med Food; 2019 Aug; 22(8):771-778. PubMed ID: 31268403
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
Yang H; Hirooka K; Fukuda K; Shiraga F
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5800-4. PubMed ID: 19608537
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma.
Huang S; Huang P; Lin Z; Liu X; Xu X; Guo L; Shen X; Li C; Zhong Y
Exp Eye Res; 2018 Mar; 168():33-48. PubMed ID: 29326065
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of thioredoxins 1 and 2 increases retinal ganglion cell survival after pharmacologically induced oxidative stress, optic nerve transection, and in experimental glaucoma.
Caprioli J; Munemasa Y; Kwong JM; Piri N
Trans Am Ophthalmol Soc; 2009 Dec; 107():161-5. PubMed ID: 20126492
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model.
Wu X; Pang Y; Zhang Z; Li X; Wang C; Lei Y; Li A; Yu L; Ye J
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):411-421. PubMed ID: 30811524
[TBL] [Abstract][Full Text] [Related]
14. Parenteral Na
Drapala A; Koszelewski D; Tomasova L; Ostaszewski R; Grman M; Ondrias K; Ufnal M
Acta Biochim Pol; 2017; 64(3):561-566. PubMed ID: 28753683
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma.
Lauzi J; Anders F; Liu H; Pfeiffer N; Grus F; Thanos S; Arnhold S; Prokosch V
PLoS One; 2019; 14(1):e0207190. PubMed ID: 30673694
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma.
Huang S; Huang P; Yu H; Lin Z; Liu X; Shen X; Guo L; Zhong Y
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4346-4359. PubMed ID: 31626691
[TBL] [Abstract][Full Text] [Related]
17. Biological Effects of Morpholin-4-Ium 4 Methoxyphenyl (Morpholino) Phosphinodithioate and Other Phosphorothioate-Based Hydrogen Sulfide Donors.
Nin DS; Idres SB; Song ZJ; Moore PK; Deng LW
Antioxid Redox Signal; 2020 Jan; 32(2):145-158. PubMed ID: 31642346
[No Abstract] [Full Text] [Related]
18. GYY4137, a novel water-soluble, H2S-releasing molecule.
Rose P; Dymock BW; Moore PK
Methods Enzymol; 2015; 554():143-67. PubMed ID: 25725521
[TBL] [Abstract][Full Text] [Related]
19. The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss.
Blanco R; Martínez-Navarrete G; Valiente-Soriano FJ; Avilés-Trigueros M; Pérez-Rico C; Serrano-Puebla A; Boya P; Fernández E; Vidal-Sanz M; de la Villa P
Exp Eye Res; 2017 Nov; 164():37-45. PubMed ID: 28827028
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide.
Li L; Whiteman M; Guan YY; Neo KL; Cheng Y; Lee SW; Zhao Y; Baskar R; Tan CH; Moore PK
Circulation; 2008 May; 117(18):2351-60. PubMed ID: 18443240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
